Gene therapy trial for blistering skin condition advancing to next phase – ModernMedicine
ModernMedicine |
Gene therapy trial for blistering skin condition advancing to next phase
ModernMedicine The companies behind the development of FCX-007, a gene therapy treatment for recessive dystrophic epidermolysis bullosa (RDEB), announced that safety data on the first of six patients treated with FCX-007 shows no adverse events. RDEB is the most … |
